Entrar/Registro  
HOME SPANISH
 
Revista Médica del Instituto Mexicano del Seguro Social
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Revista Médica del Instituto Mexicano del Seguro Social >Year 2009, Issue 1


Hernández-Valencia M, Zárate A
Endometriosis. Pathophysiological Background for Treatment
Rev Med Inst Mex Seguro Soc 2009; 47 (1)

Language: Español
References: 34
Page: 57-60
PDF: 31.60 Kb.


Full text




ABSTRACT

Endometriosis is the third cause of gynecological morbidity and the complications are associated to ectopically endometrial tissue implantation. The interest on this disease is the functional disability and its association with sterility. It has been established that endometrial growth is estrogen-dependent and that progesterone inhibits the cellular proliferation mediated by estrogens, therefore in endometriosis there is not an adequate response to hormonal signals that control the proliferative activity. It has been described that peritoneal fluid in women with endometriosis has high cytokines concentrations, growth factors and activated macrophages, which had shown adverse effects on fertility. Therefore, these are not the only causes of infertility since it has been described that endometriosis seems to have poor ovarian reserve and ovular quality. When there is infertility, the tendency is to treat the endometriosis due to the changes caused by ectopically tissue presented at immunological level and in the structure of genital organs, which disturbances the conception process. It has been observed that endometriosis has recurrences after a surgical procedure. For this reason we should be consider all therapeutic possibilities.


Key words: endometriosis, infertility, aromatase.


REFERENCIAS

  1. Zárate A, Villalobos M, Hernández-Valencia M. El enigma de la endometriosis. Rev Fac Med UNAM 1995;38:31-34.

  2. Hernández-Valencia M, Zárate A, Hernández QT, Landero MOME, Escamilla GG. Endometriosis en cicatriz tardía de episiorrafia posparto eutócico. Aspectos integrales y reporte de un caso. Rev Med IMSS 2005;43(2):237-242.

  3. Giudice L, Kao LC. Endometriosis. Lancet 2004;364 (9447):1789-1799.

  4. Moen MH, Stokstad T. A long-term follow-up study of women with asymptomatic endometriosis diagnosed incidentally at sterilization. Fertil Steril 2002; 78(4):773-776.

  5. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Osteen K, et al. Expression profiling of endometrium from woman with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003;144(7):2870-2881.

  6. Snesky TE, Liu DT. Endometriosis: associations with menorrhagia, infertility, and oral contraceptives. Int J Gynaecol Obstet 1980;17(6):573-576.

  7. Lessey BA. Medical management of endometriosis and infertility. Fertil Steril 2000;73(6):1089-1096.

  8. Grodstein F, Goldman MB, Cramer DW. Infertility in women and moderate alcohol use. Am J Public Health 1994;84(9):1429-1432.

  9. Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril 2002;77(6):1148-1155.

  10. Hernández QT, Hernández-Valencia M, Zárate A, Pérez FE. Endometriosis: ¿Es un problema de las señales inmunológicas? Ginecol Obstet Mex 2005; 7(9)3:492-499.

  11. Bedaiwy MA, Falcone T. Peritoneal fluid environment in endometriosis: Clinicopathological implications. Minerva Gynecol 2003;55(4):333-345.

  12. Braun DP, Dmowski WP. Endometriosis: abnormal endometrium and dysfunctional immune response. Curr Opin Obstet Gynecol 1998;10(5):365-369.

  13. Clayton RD, Duffy SR, Wilkinson N, Garry R, Jackson AM. Anti-proliferative affect of mycobacteria, IFN-gamma and TNF-alpha on primary cultures derived from endometrial stroma: possible relevance to endometriosis? Am J Reprod Immunol 2004;51(1):63-70.

  14. MaLaren J, Prentice A, Chamock-Jones DS, Smith SK. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1996;11(1):220-223.

  15. Laufer MR, Goitein L, Bush M, Cramer DW, Emans SJ. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J Pediatr Adolesc Gynecol 1997;10(4):199-202.

  16. Darrow SL, Vena JE, Batt RE, Zielezny MA, Michalek AM, Selman S. Menstrual cycle characteristics and the risk of endometriosis. Epidemiology 1993; 4(2):135-142.

  17. Zondervan KT, Yudkin PL, Vessey MP, Dawes MG, Barlow DH, Kennedy SH. Patterns of diagnosis and referral in women consulting for chronic pain in UK primary care. Br J Obstet Gynaecol 1999;106(11):1156-1161.

  18. Aboulghar MA, Mansour RT, Serour GI. Treatment of recurrent chocolate cysts by transvaginal aspiration and tetracycline sclerotherapy. J Assist Reprod Genet 1993;10(8):531-533.

  19. Brosens I. Endometriosis and the outcome of in vitro fertilization. Fertil Steril 2004;81(5):1198-1200.

  20. Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997;68(4):585-595.

  21. Beretta P, Franchi M, Ghezzi F, Busacca M, Zupi E, Bolis P. Randomized clinical trial of two laparoscopic treatments of endometriomas: cystectomy versus drainage and coagulation. Fertil Steril 1998;70(6):1176-1180.

  22. Candiani GB, Fedele L, Vercellini P, Bianchi S, Di Nicola G. Repetitive conservative surgery for recurrence of endometriosis. Obstet Gynecol 1991; 77(3):421-424.

  23. Mol BW, Bayram N, Lijmer JG, Wiegerinck MA, Bongers MY, van der Veen F, et al. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril 1998; 70(6):1101-1108.

  24. Harada T, Kubota T, Aso T. Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis. Fertil Steril 2002;78(4):733-739.

  25. D'Hooghe TM, Mihalyi AM, Simsa P, Kyama CK, Peeraer K, De Loecker P, Meeuwis L, Segal L, Meuleman C. Why we need a noninvasive diagnostic test for minimal to mild endometriosis with a high sensitivity. Gynecol Obstet Invest 2006;62(3):136-138.

  26. Brosens I, Puttemans P, Campo R, Gordts S, Brosens J. Non-invasive methods of diagnosis of endometriosis. Curr Opin Obstet Gynecol 2003;15(6):519-522.

  27. Valle RF, Sciarra JJ. Endometriosis: treatment strategies. Ann NY Acad Sci 2003;997:229-239.

  28. Namnoum AB, Hickman TN, Goodman SB, Gehibach DL, Rock JA. Incidence of symptom recurrence after hysterectomy for endometriosis. Fertil Steril 1995;64 (5):898-902.

  29. Olive DL, Lindheim SR, Pritts EA. New medical treatments for endometriosis. Best Pract Res Clin Obstet Gynecol 2004;18(2):319-328.

  30. Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril 1993;60(1):75-79.

  31. Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996;81:174-179.

  32. Attar E, Bulun SE. Aromatase inhibitors: the next wave in treatment of endometriosis? Fertil Steril 200;85(5):1307-1318.

  33. Vercellini P, Frontino G, De Giorgio O, Aimi G, Zaina B, Crosignani PG. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management alter conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril 2003;80(2)305-309.

  34. Nap AW, Groothuis PG, Demir AY, Evers JL, Dunselman GA. Pathogenesis of endometriosis. Best Pract Res Clin Obstet Gynaecol 2004;18(2):233-244.






>Journals >Revista Médica del Instituto Mexicano del Seguro Social >Year 2009, Issue 1
 

· Journal Index 
· Links 






       
Copyright 2019